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Purpose: Magnetic resonance imaging is playing an ever‐bigger role in the manage-
ment of prostate cancer. This study investigated barriers to obtaining multi‐paramet-
ric MRI (mpMRI) in African‐American men on active surveillance for prostate 
cancer in comparison to white men affected by the same type of cancer.
Materials and Methods: Retrospective review of prostate mpMRI orders from 
August 2015 to October 2017 at a single health organization treating a diverse popula-
tion was performed. Data was extracted from the electronic medical records and can-
cellations were examined based on the documented reason for mpMRI cancellation, 
race, median zip code household income, and distance from healthcare facility.
Results: Out of 793 prostate mpMRI orders, 201 (25%) went unscanned. Access to 
care issues accounted for 46% of unscanned orders. Patient cancellations were the 
most common, followed by difficulty contacting patients, and insurance denials. 
African‐American patients disproportionately went unscanned because institution 
staff were unable to contact patients (29% vs 10% in white men, P = 0.0015). Median 
zip code household income was significantly different between racial groups but did 
not vary between indication for cancellation.
Conclusions: African‐American prostate cancer patients’ access to mpMRI is hin-
dered more by barriers to care than White patients. Urology providers must consider 
these issues before using prostate mpMRI within their active surveillance pathways.
K E Y W O R D S
health services accessibility, magnetic resonance imaging, prostate cancer
1 |  INTRODUCTION
Among men, prostate cancer is the most common nonder-
matologic cancer and one of the top three causes of cancer 
death.1 Transrectal ultrasound‐guided (TRUS) biopsy is the 
current standard diagnostic procedure for prostate cancer; this 
method randomly samples the prostate with a sensitivity as 
low as 60%.2 In recent years, the utilization of multiparametric 
magnetic resonance imaging (mpMRI) has paved the way for 
MRI‐targeted biopsy (TB). With this approach, patients with 
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highly suspicious lesions on mpMRI are counseled on the ben-
efit of MRI‐TB and given the option of undergoing a biopsy of 
the prostate. In the published literature, compared with TRUS 
biopsy, mpMRI has higher sensitivity and negative predictive 
value for clinically significant cancer (Gleason score 4 + 3 or 
higher, volume ≥0.5 cm, or aggressively invasive cancers).3 
As such, mpMRI identifies significant cancers—those that re-
quire treatment—and protects up to 25% of patients from the 
risks of an unnecessary biopsy.3,4
The American Urological Association (AUA) recognizes 
the usefulness of mpMRI in pre‐biopsy risk stratification 
of patients being evaluated for prostate cancer. It correlates 
well with the likelihood of clinically significant lesions and 
likelihood of progression on active surveillance.5 In a large, 
prospective active surveillance cohort, unchanged mpMRI 
had an 80% negative predictive value for biopsy upgrade to 
clinically significant cancer.6 Lack of standardization in re-
peat mpMRI for surveillance is a limitation in its use for in 
monitoring men on active surveillance. Therefore, while the 
AUA considers mpMRI beneficial for stratifying men into 
active surveillance protocols, they recommend a combination 
of molecular markers, repeat mpMRI imaging, and biopsy for 
monitoring men on active surveillance.5
Considering growing evidence supporting the advan-
tages of MRI‐TB over the ultrasound‐guided approach, it is 
important to understand barriers limiting patients from pur-
suing this diagnostic approach. This study aimed to identify 
reasons and barriers for incomplete unscanned prostate mp-
MRIs in patients who are scheduled to undergo MRI‐TB at 
a large community health organization. Accessing a large 
African‐American population has enabled our organization 
to examine race as a determining factor in a patient's chance 
to receive mpMRI during the course of active surveillance for 
prostate cancer.
2 |  MATERIALS AND METHODS
This is a retrospective review of prostate mpMRI ordered 
from August 2015 to October 2017 at a large health care 
organization treating a diverse population the metro Detroit 
area. The urology department at this institution manages 
1800 patients with prostate cancer on a yearly basis, 35% 
of whom identify as African American. After institutional 
review board approval, data were extracted from the elec-
tronic medical records (EMRs) with case by case review by 
researchers to confirm the accuracy of the data. All prostate 
mpMRI orders during the study dates were identified and ex-
tracted into a database.
Variables collected included date the mpMRI was ordered, 
date of birth, ethnicity, zip code, indication for mpMRI, 
and documented reason for mpMRI cancellation. Patients 
were excluded from analysis if they did not have complete 
information. Patient age was calculated from date of birth and 
date the mpMRI was ordered. Median household income was 
extracted by zip code from the 2016 American Community 
Survey. Distance from hospital was calculated as the distance 
between the center of the patient's zip code and the healthcare 
institution where patients were seen by providers. Unscanned 
mpMRIs were categorized based on the documented reason 
for mpMRI cancellation, the primary outcome of interest in 
this study. Categories were “patient cancellation,” “provider 
cancellation,” “not contacted,” “scanned at outside institu-
tion,” “medical condition,” and “insurance.”
Descriptive statistics for categorical variables included 
frequencies and proportions. Chi‐square tests with Pearson 
residuals were utilized for statistical analysis of categori-
cal variables. Analysis of variance (ANOVA) with Tukey's 
honest significance tests (HSD) were utilized for statistical 
analysis of continuous variable. Univariate and multivariate 
logistic regression using African American and White pa-
tients within 100 miles of the hospital was also performed 
with SAS 9.4 in order to identify variables significantly asso-
ciated with completed mpMRI. Tests were two‐sided with an 
alpha value of 0.05.
3 |  RESULTS
During the study period ranging from August 2015 to October 
2017, 793 prostate mpMRIs were ordered. Of these, 749 had 
complete information extracted from the EMR. A total of 
201 25%) mpMRI orders were never completed, 175 with 
complete information available in the EMR. Patient charac-
teristics for scanned and unscanned orders are displayed in 
Table 1; patients with incomplete orders ranged in age from 
37 to 88 years old, with 68% identifying as White and 28% 
identifying as African American. Unscanned orders were cat-
egorized based on indication for mpMRI cancellation. Table 
2 displays frequencies by ethnicity for each indication.
Among African‐American patients whose mpMRIs went 
unscanned, the most common cause of not undergoing imag-
ing was difficulty contacting patients. Difficulty contacting 
patients, insurance denials, and patient cancellations are all 
barriers to care. Combined, this makes access to care issues 
(46%) the most common indication for an unscanned prostate 
mpMRI. Among these three barriers patient cancellation was 
most common overall, followed by difficulty contacting pa-
tients and insurance denials. Other reasons for cancellation 
included medical contraindications (16%) and imaging off-
site (13%).
Indication for cancellation was not equally distrib-
uted between racial groups [Χ2 (5, N = 165) = 19.58, 
P = 0.0015]. Pearson residuals indicate prostate mpMRIs 
of African‐American patients disproportionately went un-
scanned because it was difficult to contact patients (29% vs 
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10% in white males); prostate mpMRIs of White patients 
were disproportionately cancelled by providers. Among 
patients unable to be contacted, a median of two attempts 
were made without a statistical difference between racial 
groups (F = 0.8988, P = 0.551). Provider cancellations oc-
curred 56% of the time due to duplicate or incorrect EMR 
order. Therapy was escalated (ie, radiation or directly to 
biopsy) in five cases and de‐escalated in two cases due to 
decreased prostate‐specific antigen (PSA).
Using median household incomes from subjects’ zip 
codes, the average household income of the unscanned 
study population was $65 558, which did not differ from 
the scanned population that had an average household 
income of $64 808 P = 0.7002). Median zip code house-
hold incomes stratified by ethnicity are displayed in Table 
1 and by indication for cancellation in Table 3. African‐
American patients live in zip codes with a median house-
hold income statistically lower than White patients and 
patients of unknown ethnicity F = 12.7861, P < 0.0001). 
On average, the median zip code household income of 
African‐American patients was $49 853 but the median 
zip code household income of White patients was $71 892 
and the median household income of other ethnicities was 
$69 625. However, within each ethnic group the median 
household income did not differ between the scanned and 
unscanned populations. Patients who went off‐site were 
from wealthier zip codes $73 393) and patients who were 
not contacted or have medical contraindications to mpMRI 
live in less wealthy areas $62 824 and $61 803, respec-
tively). Table 4 demonstrates this pattern is consistent 
among African American patients, but not White patients. 
That being said, the median zip code household income 
was not statistically different from indication for cancella-
tion, even when separated by ethnicity.
Racial groups were distributed similarly between the 
scanned and unscanned populations. This remained true 
when nonaccess to care explanations ie, went offsite, du-
plicate order, incorrect order) for unscanned mpMRI were 
excluded from analysis. Univariate logistic regression, dis-
played in Table 5, did not identify any association between 
Characteristic Scanned (n = 574)
Unscanned 
(n = 175) P‐value
Age—mean (SD) 65.4 (8.9) 65.4 (8.4) 1.000
Ethnicity, n (%)
White 388 (67.6) 119 (68.0) 0.5003a 
African American 150 (26.1) 49 (28.0)
Other 36 (6.27) 7 (4.0)
Median zip code household income in 
thousands of USD—mean (SD)
64.8 (25.4) 65.6 (25.8)b 0.7089
White 70.9 (25.6) 71.9 (24.3) 0.7002
African American 47.9 (23.9) 49.9 (28.1) 0.6395
Other 75.1 (25.6) 69.6 (31.7) 0.6183
aΧ2 (2, N = 749) = 1.38. 
bANOVA: F = 12.7861, P < 0.0001. 
T A B L E  1  Characteristics of patients 
with an EMR order placed for prostate 
mpMRI
T A B L E  2  Indications for cancelled prostate mpMRI by racial group
Ethnicity
Indication—n (% of the column)
Provider cancelled Patient cancelled Medical condition Not contacted Went off‐site Insurance
White 37 (88%) 23 (83%) 16 (57%) 11 (44%) 12 (67%) 15 (68%)
African American 5 (12%) 5 (17%) 12 (43%) 14 (56%) 6 (33%) 7 (32%)
Χ2 (5, N = 165) = 19.58, P = 0.0015.
T A B L E  3  Median zip code household income in USD by 
indication for cancellation
Indication for cancellation
Median Zip code household 
income in USD—mean (SD)
Patient cancelled 68 568 (21 077)
Not contacted 62 824 (33 876)
Went off‐site 73 393 (24 539)
Medical condition 61 803 (31 230)
Insurance 66 748 (33 693)
Provider cancelled 68 030 (22 620)
ANOVA: F = 0.6780, P = 0.6406.
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patient age, ethnicity, median zip code household income, or 
distance from the healthcare institution and scanned mpMRI 
order. This was confirmed with multivariate logistic regres-
sion for each of these variables, displayed in Table 6.
4 |  DISCUSSION
Access to care has been defined by five dimensions: avail-
ability, accessibility, accommodation, affordability, and ac-
ceptability.7 Some of the important barriers to access to care 
include difficulty contacting patients which represent a fail-
ure in the realm of accommodation, or the manner in which 
a medical facility accepts patients and the ability of clients to 
meet those constraints. Another barrier is insurance denials 
which represent a failure within affordability. Patient can-
cellations likely occurred due to failures in any of the five 
dimensions. That is, it is reasonable to expect patient cancel-
lations because they cannot find an acceptable appointment 
time (availability); do not have transportation (accessibility); 
cannot navigate the healthcare system (accommodation); 
cannot afford the procedure (affordability); or they dislike 
the facility (acceptability). In this study, we are the first to 
report that barriers to access to care were the most common 
indication for unscanned prostate mpMRI orders, and that 
these barriers affected African‐American patients more than 
White patients treated in the same metro area.
In this study, African‐American patients struggled with 
access to care more than White patients. This is reflected by 
the disproportionate number of African‐American patients 
with prostate mpMRIs cancelled due to difficulty contacting 
the patient. PSA screening among African‐American patients 
supports the idea that access to care issues contribute to this 
finding. African‐American patients who found the healthcare 
system inconvenient or who found it difficult to receive qual-
ity care were less likely to complete a PSA test.8
It has been shown that patients’ socioeconomic status 
(SES) is often the primary cause for radiological study can-
cellation.9 For example, SES is a major barrier for patients 
to obtain screening tests for breast cancer; patient awareness 
and knowledge about breast cancer has been reported as a 
barrier to obtaining a mammography in older women regard-
less of financial status.10,11 Evidence points to health dispar-
ities in all fields of medicine, including urology. Individuals 
of lower SES travel farther for care, receive care less often at 
high‐volume institutions, and present with higher grade pros-
tate cancer.12-14
From a SES perspective, epidemiological evidence 
indicates African‐American residents of Metropolitan 
Detroit disproportionately inhabit lower SES neighbor-
hoods. Statistically lower median household income in 
the zip codes of the African‐American patients in this 
study—compared with White patients—supports this idea. 
15,16 Furthermore, lower SES individuals engage with 
T A B L E  4  Median zip code household income in USD by indication for cancellation amongst African American and White patients
African American patients—mean (SD) White patients—mean (SD)
Patient cancelled 54 818 (23 107) Patient cancelled 68 889 (19 879)
Not contacted 47 213 (33 740) Not contacted 74 421 (21 119)
Went off‐site 60 499 (25 279) Went off‐site 73 605 (25 219)
Medical condition 40 538 (16 932) Medical condition 73 252 (28 365)
Insurance 51 854 (39 631) Insurance 78 698 (31 332)
Provider cancelled 59 064 (25 968) Provider cancelled 69 811 (22 538)
ANOVA: F = 0.5816, P = 0.7138 ANOVA: F = 0.4050, P = 0.8444
T A B L E  5  Univariate logistic regression analysis of 612 patients for completion of mpMRI scanning after order placement SAS 9.4
Predictor β SE β Wald's χ2 df P‐value Odds ratio
Intercept 1.5062 0.8243 3.3389 1 0.0677 4.509
Age 0.0014 0.0125 0.0120 1 0.9128 1.001
Intercept 1.5447 0.1137 184.73 1 <0.0001 4.687
African American ethnicity −0.1517 0.1137 1.7826 1 0.1818 0.859
Intercept 1.3893 0.2749 25.534 1 <0.0001 4.012
Household income 0.0000 0.0000 0.6385 1 0.4243 1.000
Intercept 1.2376 0.2107 34.496 1 <0.0001 3.447
Distance from care 0.0173 0.0090 3.7284 1 0.0535 1.017
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digital health technology less than their higher SES coun-
terparts.17 Therefore, it is reasonable to extrapolate that de-
creased engagement with health technology could explain 
communication difficulties amongst African‐American pa-
tients. Interestingly, in our study, median zip code house-
hold income was not significantly different when patients 
were grouped by indication for cancellation or when com-
pared between African‐American patients with complete 
and incomplete mpMRI orders. This suggests that while 
lower income may play a role in why African‐American 
patients were successfully contacted less frequently than 
their White counterparts, it does not explain all variation. 
Another explanation for the lack of association between 
lower income and the decreased likelihood of mpMRI 
scanning is the small sample size of our study population 
precluding enough power to detect significant difference in 
the variables of interest.
Regarding implicit bias, substantial evidence suggests 
physicians and lay persons have similar degrees of bias. 
Both groups have higher levels of bias towards non‐White 
individuals, which can unconsciously have a negative impact 
on treatment adherence, patient‐physician relationships, and 
health outcomes.18 Thus, it is feasible that implicit bias may 
influence which patients’ healthcare staff struggled to con-
tact. It is unlikely healthcare staff invested less energy to 
contact African‐American patients than White patients as 
they made the same average number of attempts at com-
munication. Furthermore, the staff responsible for patient 
communication at the study institution are overwhelming 
African American and female, two demographics known 
to show lower levels of implicit bias. 19 It's also possible 
African American patients unconsciously felt distanced 
from their providers and elected to not participate in further 
communication. Future investigation of this health disparity 
might benefit from a measure of implicit bias, however, in-
clusion of that type of measure in this study was not possible 
due to its retrospective nature.
Provider cancellations were the most common individual 
reason for an unscanned prostate mpMRI among White pa-
tients. This categorization includes duplicate orders, incor-
rect orders (eg, liver and prostate mpMRI changed to prostate 
mpMRI), and clinical judgement (eg, replaced with surgery/
TRUS biopsy). Duplicate and incorrect orders account for 
over half of cancellations in this category. This is not an un-
expected finding as cancellations due to duplicate orders tend 
to increase with EMR implementation.20 As such, provider 
cancellation likely reflects either user error, unfamiliarity 
with the EMR system, or increased radiologist recognition of 
duplicate orders. Importantly, they do not reflect a barrier to 
care because they are logistical errors that do not influence 
patient outcomes.
Among the remaining indications for prostate mpMRI 
cancellation, only insurance denials represent a social issue. 
This signifies a need within the urological community to pro-
duce further research and advocacy campaigns that compel 
insurance companies to cover MRI‐TB. Medical contraindi-
cations primarily encompass obesity, claustrophobia, and im-
plants incompatible with the MRI machine. The former two 
can be resolved with open MRI machines and anxiolytics, re-
spectively. Finally, offsite MRI is not truly a barrier to care as 
patients can still proceed with MRI‐TB once medical records 
are shared between institutions.
Overall, we think this study provides important insight 
into the difficulty of active surveillance pathways that uti-
lize mpMRI as a way to manage African‐American patients, 
which is ensuring compliance with follow‐up. In fact, our 
patients who could not be accessed to attend their mpMRI 
were not compliant with the rest of their visits for active 
surveillance (data not shown). Based on the results of this 
study and pending validation of our findings from other 
similar healthcare systems, urology providers may want to 
strongly consider addressing access to care barriers when or-
dering prostate mpMRI for their patients, specifically those 
patients who identify as African American. Providers may 
also want to consider investigating whether patients feel their 
healthcare facility is available, accessible, accommodating, 
affordable, and acceptable. Resolving issues in these five di-
mensions will reduce the number of patient cancelled pros-
tate mpMRIs, which are the most common barrier to imaging 
and the most common reason for cancellation (if duplicate 
orders are excluded). Providers need to develop methods to 
ensure their clinic staff can contact all patients prior to sched-
ule appoints, especially African American patients who are 
disproportionately affected by this barrier. Part of this may 
require accommodations to meet the needs of lower SES pa-
tients. In addition, insurance barriers should be addressed for 
T A B L E  6  Multivariate logistic regression analysis of 603 patients for completion of mpMRI scanning after order placement SAS 9.4
Predictor β SE β Wald's χ2 df P‐value Odds ratio
Intercept 1.0498 0.8908 1.3887 1 0.2386 2.857
Age 0.0033 0.0127 0.0660 1 0.7972 1.003
African American ethnicity −0.0831 0.1339 0.3850 1 0.5349 0.920
Household income −0.0000 0.0000 0.0265 1 0.8707 1.000
Distance from care 0.0164 0.0102 2.5586 1 0.1097 1.017
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all patients, as this represents a small, yet clinically signifi-
cant segment of unscanned prostate mpMRIs. Finally, active 
surveillance pathways that are specifically designed for pa-
tients who may not be able to overcome barriers to care are 
in dire need, and active treatment may be a better option if 
the provider objective assessment of the patient leads them 
to believe that safe active surveillance management is not 
achievable in that particular patient.
A limitation of this study is that we could not account 
for the intrinsic bias in deciding who an MRI should be 
ordered for based on our retrospective methods. In patients 
who obviously would not have been able to attend the MRI 
(for financial reasons, transportation reasons, etc), the pro-
vider may have decided to just not order the mpMR, and the 
patient would not be captured in this study. Another limita-
tion because of our retrospective design is if patients had 
previously had an MRI ordered at another institution and 
did not therefore need an MRI ordered at our institution, 
then these patients would also not be captured in the group 
of patients who obtained access to an MRI. To try to cor-
rect for this limitation, we reviewed the patients’ records 
through CareEverywhere in EPIC©, an electronic medical 
record that allows us to retrieve patients past medical his-
tory from the major medical systems in Michigan, and very 
few record showed evidence of previous MRI orders. These 
few orders of MRI outside our system would not have af-
fected the results of our analysis, and in fact may bias our 
conclusions towards showing African Americans face 
more barriers than White patients, which was a conclusion 
of the study. Also, not undergoing mpMRI could be related 
to lack of understanding of the value of the test, mistrust, 
or lack of education by the provider which are factors that 
we did not measure in this study. Finally, there are multiple 
reports regarding the racial disparities in the United States 
regarding screening, care and outcomes in prostate cancer, 
but we feel that the growing role of MRI in managing pros-
tate cancer calls for an analysis of the quality of access of 
African‐American men to this important diagnostic tool.
5 |  CONCLUSIONS
When obtaining mpMRI in patients considering active sur-
veillance for prostate cancer; African‐American patients are 
more impacted with barriers to access to care than White pa-
tients. As a result, urology providers must consider access to 
care issues in African‐American patients before recommend-
ing prostate mpMRI.
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